HALLURA Trademark
Serial Number: 79325281 • Registration: 6920290
HALLURA is a trademark filed by
HALLURA LTD.
on June 2, 2021. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Roy D. Gross The Roy Gross Law Firm, LLC
50 Washington Street
Suite 910/911
Norwalk
CT 06854
Trademark Details
Filing Date
June 2, 2021
Registration Date
December 13, 2022
Published for Opposition
September 27, 2022
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 24, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 1, 2023 FICS
FINAL DISPOSITION PROCESSED
Mar 31, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 13, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 13, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 13, 2022 R.PR
LIMITATION FROM THE IB EXAMINED AND ENTERED
Oct 31, 2022 LIME
NOTIFICATION PROCESSED BY IB
Sep 27, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 27, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 27, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 7, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 7, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 7, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 22, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 20, 2022 TROA
LIMITATION OF GOODS RECEIVED FROM IB
Jul 3, 2022 LIMG
REFUSAL PROCESSED BY IB
Mar 14, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 22, 2022 RFCS
REFUSAL PROCESSED BY MPU
Feb 22, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 19, 2022 RFCR
NON-FINAL ACTION WRITTEN
Feb 18, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 17, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 19, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 15, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 11, 2021 REPR
